164 related articles for article (PubMed ID: 27139600)
21. Calreticulin Mutations in Bulgarian MPN Patients.
Pavlov I; Hadjiev E; Alaikov T; Spassova S; Stoimenov A; Naumova E; Shivarov V; Ivanova M
Pathol Oncol Res; 2018 Jan; 24(1):171-174. PubMed ID: 28411309
[TBL] [Abstract][Full Text] [Related]
22. Calreticulin mutation profile in Indian patients with primary myelofibrosis.
Sazawal S; Singh N; Mahapatra M; Saxena R
Hematology; 2015 Dec; 20(10):567-70. PubMed ID: 25959795
[TBL] [Abstract][Full Text] [Related]
23. Rare type 1-like and type 2-like calreticulin mutants induce similar myeloproliferative neoplasms as prevalent type 1 and 2 mutants in mice.
Toppaldoddi KR; da Costa Cacemiro M; Bluteau O; Panneau-Schmaltz B; Pioch A; Muller D; Villeval JL; Raslova H; Constantinescu SN; Plo I; Vainchenker W; Marty C
Oncogene; 2019 Mar; 38(10):1651-1660. PubMed ID: 30846848
[TBL] [Abstract][Full Text] [Related]
24. Calreticulin Mutations in Myeloproliferative Neoplasms: Comparison of Three Diagnostic Methods.
Park JH; Sevin M; Ramla S; Truffot A; Verrier T; Bouchot D; Courtois M; Bas M; Benali S; Bailly F; Favre B; Guy J; Martin L; Maynadié M; Carillo S; Girodon F
PLoS One; 2015; 10(10):e0141010. PubMed ID: 26501981
[TBL] [Abstract][Full Text] [Related]
25. A novel assay to detect calreticulin mutations in myeloproliferative neoplasms.
Rosso V; Petiti J; Bracco E; Pedrola R; Carnuccio F; Signorino E; Carturan S; Calabrese C; Bot-Sartor G; Ronconi M; Serra A; Saglio G; Frassoni F; Cilloni D
Oncotarget; 2017 Jan; 8(4):6399-6405. PubMed ID: 28031530
[TBL] [Abstract][Full Text] [Related]
26. A novel molecular assay using hybridisation probes and melt curve analysis for
Keaney T; O'Connor L; Krawczyk J; Abdelrahman MA; Hayat AH; Murray M; O'Dwyer M; Percy M; Langabeer S; Haslam K; Glynn B; Mullen C; Keady E; Lahiff S; Smith TJ
J Clin Pathol; 2017 Aug; 70(8):662-668. PubMed ID: 28143941
[TBL] [Abstract][Full Text] [Related]
27. Diversities of Calreticulin Gene Mutations in Macedonian Patients With Essential Thrombocythemia.
Panovska-Stavridis I; Eftimov A; Ivanovski M; Stojanovic A; Georgievski B; Cevreska L; Dimovski AJ
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):477-81. PubMed ID: 27521277
[TBL] [Abstract][Full Text] [Related]
28. Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3.
Bonnet S; Carillo S; Legrand B; Burroni B; Lavabre-Bertrand T; Requirand G; Robert N; Fornero L; Al Mansoori A; Moreaux J; Cartron G; Gabellier L; Herbaux C
Eur J Haematol; 2024 Mar; 112(3):475-478. PubMed ID: 37918825
[TBL] [Abstract][Full Text] [Related]
29. Rapid detection of CALR type 1 and type 2 mutations using PNA-LNA clamping loop-mediated isothermal amplification on a CD-like microfluidic chip.
Cao G; Kong J; Xing Z; Tang Y; Zhang X; Xu X; Kang Z; Fang X; Guan M
Anal Chim Acta; 2018 Sep; 1024():123-135. PubMed ID: 29776538
[TBL] [Abstract][Full Text] [Related]
30. Somatic mutations of calreticulin in myeloproliferative neoplasms.
Klampfl T; Gisslinger H; Harutyunyan AS; Nivarthi H; Rumi E; Milosevic JD; Them NC; Berg T; Gisslinger B; Pietra D; Chen D; Vladimer GI; Bagienski K; Milanesi C; Casetti IC; Sant'Antonio E; Ferretti V; Elena C; Schischlik F; Cleary C; Six M; Schalling M; Schönegger A; Bock C; Malcovati L; Pascutto C; Superti-Furga G; Cazzola M; Kralovics R
N Engl J Med; 2013 Dec; 369(25):2379-90. PubMed ID: 24325356
[TBL] [Abstract][Full Text] [Related]
31. Calreticulin Mutation by Immunohistochemistry: Can It Replace PCR?
Gupta A; Sazawal S; Mahapatra M; Pati HP; Saxena R
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):621-626. PubMed ID: 31478923
[TBL] [Abstract][Full Text] [Related]
32. Calreticulin mutation analysis in non-mutated Janus kinase 2 essential thrombocythemia patients in Chiang Mai University: analysis of three methods and clinical correlations.
Rattarittamrong E; Tantiworawit A; Kumpunya N; Wongtagan O; Tongphung R; Phusua A; Chai-Adisaksopha C; Hantrakool S; Rattanathammethee T; Norasetthada L; Charoenkwan P; Lekawanvijit S
Hematology; 2018 Oct; 23(9):613-619. PubMed ID: 29521158
[TBL] [Abstract][Full Text] [Related]
33. [Detection of JAK2V617F and CALR Gene Mutations by Multiplex of Patients with Myeloproliferative Neoplasms PCR-Capillary Electrophoresis].
Yuan JL; Shi YX; DU H; Wang YJ; Zhao ZL; Li G; Han YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1998-2003. PubMed ID: 33283732
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms.
Jones AV; Ward D; Lyon M; Leung W; Callaway A; Chase A; Dent CL; White HE; Drexler HG; Nangalia J; Mattocks C; Cross NC
Leuk Res; 2015 Jan; 39(1):82-7. PubMed ID: 25499808
[TBL] [Abstract][Full Text] [Related]
35. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
Michiels JJ; Berneman Z; Schroyens W; De Raeve H
Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
[TBL] [Abstract][Full Text] [Related]
36. Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression.
Cottin L; Riou J; Orvain C; Ianotto JC; Boyer F; Renard M; Truchan-Graczyk M; Murati A; Jouanneau-Courville R; Allangba O; Mansier O; Burroni B; Rousselet MC; Quintin-Roué I; Martin A; Sadot-Lebouvier S; Delneste Y; Chrétien JM; Hunault-Berger M; Blanchet O; Lippert E; Ugo V; Luque Paz D
Br J Haematol; 2020 Mar; 188(6):935-944. PubMed ID: 31710700
[TBL] [Abstract][Full Text] [Related]
37. The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms.
Belčič Mikič T; Pajič T; Zver S; Sever M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806036
[No Abstract] [Full Text] [Related]
38. CALR mutation profile in Irish patients with myeloproliferative neoplasms.
Haslam K; Conneally E; Flynn CM; Cahill MR; Gilligan O; O'Shea D; Langabeer SE
Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):112-5. PubMed ID: 27352261
[TBL] [Abstract][Full Text] [Related]
39. Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment.
Kjær L; Cordua S; Holmström MO; Thomassen M; Kruse TA; Pallisgaard N; Larsen TS; de Stricker K; Skov V; Hasselbalch HC
PLoS One; 2016; 11(10):e0165336. PubMed ID: 27764253
[TBL] [Abstract][Full Text] [Related]
40. A triplex probe-based TaqMan qPCR assay for Calreticulin type I and II mutation detection.
Tang Y; Shi C; Wu Z; Fan N; Xu X; Kang Z; Zhang X; Ma W; Guan M
Hematology; 2019 Dec; 24(1):26-31. PubMed ID: 30080988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
